Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
cU7kMNwHPTuNnFw6
